DNA topoisomerases I & II cleavage sites in the type 1 human immunodeficiency virus (HIV-1) DNA promoter region.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1994-12-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/BBRC.1994.2850PMID 7811242
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA topoisomerase I and II in cancer chemotherapy: update and perspectives

  2004cited by this paper
• Camptothecin inhibits Tat-mediated transactivation of type 1 human immunodeficiency virus.

  1994cited by this paper
• Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors.

  1994cited by this paper
• Sequence-specific transactivators counteract topoisomerase II-mediated inhibition of in vitro transcription by RNA polymerases I and II.

  1993cited by this paper
• DNA topoisomerase I is involved in both repression and activation of transcription

  1993cited by this paper
• When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs.

  1993cited by this paper
• Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.

  1993cited by this paper
• Inhibition of retrovirus-induced disease in mice by camptothecin

  1993cited by this paper
• Analysis of the DNA topoisomerase-II-mediated cleavage of the long terminal repeat of Drosophila 1731 retrotransposon.

  1993cited by this paper
• A cluster of strong topoisomerase II cleavage sites is located near an integrated human immunodeficiency virus.

  1993cited by this paper
• Site-specific interaction of vaccinia virus topoisomerase I with base and sugar moieties in duplex DNA.

  1993cited by this paper
• Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene.

  1992cited by this paper
• Genetic regulation of human immunodeficiency virus.

  1991cited by this paper
• Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs.

  1991cited by this paper
• Molecular biology of the human immunodeficiency virus type 1

  1991cited by this paper
• Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide.

  1991cited by this paper
• DNA topoisomerases: why so many?

  1991cited by this paper
• Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin.

  1991cited by this paper
• Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core.

  1990cited by this paper
• Nucleosome positioning as a critical determinant for the DNA cleavage sites of mammalian DNA topoisomerase II in reconstituted simian virus 40 chromatin.

  1990cited by this paper
• Identification within the simian virus 40 genome of a chromosomal loop attachment site that contains topoisomerase II cleavage sites

  1990cited by this paper
• The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I.

  1989cited by this paper
• DNA topoisomerases as potential targets of antiviral action.

  1989cited by this paper
• Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.

  1988cited by this paper
• Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavage.

  1988cited by this paper
• A consensus sequence for cleavage by vertebrate DNA topoisomerase II.

  1988cited by this paper
• Supercoiling of the DNA template during transcription.

  1987cited by this paper
• Sequence dependence of Drosophila topoisomerase II in plasmid relaxation and DNA binding.

  1987cited by this paper
• Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.

  1986cited by this paper

• Role of Host Proteins in HIV-1 Early Replication

  2016cites this paper
• TopoisomeraseIIβ in HIV-1 transactivation.

  2016cites this paper
• Topoisomerase I Alone Is Sufficient to Produce Short DNA Deletions and Can Also Reverse Nicks at Ribonucleotide Sites*

  2015cites this paper
• Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription.

  2013cites this paper
• Topoisomerase-Induced DNA Damage

  2012cites this paper
• Camptothecins for drug design, cancer cell death and gene targeting

  2008cites this paper
• A study of the topoisomerase II activity in HIV-1 replication using the ferrocene derivatives as probes.

  2006cites this paper
• A biochemical analysis of topoisomerase II alpha and beta kinase activity found in HIV-1 infected cells and virus.

  2005cites this paper
• A biochemical analysis of topoisomerase II α and β kinase activity found in HIV-1 infected cells and virus

  2005cites this paper
• 9‐Nitrocamptothecin inhibits HIV‐1 replication in human peripheral blood lymphocytes: A potential alternative for HIV‐infection/AIDS therapy

  2001cites this paper
• Syntheses, biochemical and biological evaluation of staurosporine analogues from the microbial metabolite rebeccamycin.

  1998cites this paper
• Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle.

  1998cites this paper
• Distribution of topoisomerase II-mediated cleavage sites and relation to structural and functional landmarks in 830 kb of Drosophila DNA.

  1997cites this paper
• In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.

  1997cites this paper
• Camptothecin: A Promising Antiretroviral Drug.

  1996cites this paper
• Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517.

  1995cites this paper